[CLSTR]
API
< Back to situation

[REVISION HISTORY]

Trump administration NIH policy and funding changes

9 recorded revisions of this situation.

What changed

2026-10-20 07:56 UTC → 2026-10-22 23:14 UTC · added removed

Under the Trump administration, the National Institutes of Health (NIH) has undergone significant structural and policy shifts. Initial reports indicate a talent drain as scientists relocate due to instability and mass layoffs. During the first year of the administration, directed by Donald Trump and Health Secretary Robert Kennedy Junior, approximately 1,231 research projects were terminated following the suspension or cancellation of 5,844 grants. These disruptions have reportedly impacted patients in clinical trials and been exacerbated by the rejection of diversity initiatives. To centralize control over grant distribution, President Trump previously directed White House Budget Director Russ Vought to draft an executive order establishing an oversight board composed of Vought and NIH Director Jay Bhattacharya. This board would require unanimous decisions for all grant awards, effectively granting Vought veto power over billions of dollars in biomedical research funding to ensure alignment with the administration’s priorities. This includes targeting research deemed “woke,” such as studies on diversity, equity, and inclusion, gender identity, and climate change. Researchers have reported that keyword tracking—such as flagging the term ‘trans’ in studies involving transgenic mice—has led to the cancellation Following significant pressure from members of research projects. While Congress, including Senate Appropriations Committee Chair Susan Collins and Senator Patty Murray, the administration reportedly shelved the oversight board executive order following pressure from members order. While the immediate threat of Congress, that specific order has been paused, uncertainty remains as a separate grant rule proposed by the White House budget office is still pending. In a separate move, President Trump has signed a new an executive order titled ‘Advancing establishing a new Women’s Health to Improve Outcomes in All Phases of Life.’ Division within the NIH. Spearheaded by First Lady Melania Trump, the order mandates the creation of a new Women’s Health Division within the NIH within 90 days and initiative includes a White House Women’s Health Task Force, Force co-led by Chief of Staff Susie Wiles and HHS Secretary Robert F. Kennedy Jr. The initiative focuses on five pillars, including AI-accelerated discovery and direct funding for female-specific diseases such as endometriosis and maternal health, though it does not set specific funding targets.

Versions

  1. 2026-10-22 23:14 UTC Trump administration NIH policy and funding changes
  2. 2026-10-20 07:56 UTC Trump administration NIH policy and funding changes
  3. 2026-10-20 03:02 UTC Trump administration NIH policy and funding changes
  4. 2026-10-19 23:04 UTC Trump administration NIH policy and funding changes
  5. 2026-10-19 22:44 UTC Trump administration NIH policy and funding changes
  6. 2026-10-19 20:15 UTC Trump administration NIH policy and funding changes
  7. 2026-09-25 21:21 UTC Trump administration NIH policy and funding changes
  8. 2026-09-21 15:04 UTC Trump administration NIH policy and funding changes
  9. 2026-09-20 23:58 UTC Trump administration NIH policy and funding changes
  10. 2026-09-20 09:39 UTC Trump administration NIH policy and funding changes

Select a version to see what changed compared to the one before it.